At what age is bronchiolitis (inflammation of the small airways) most likely to occur?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Age Distribution of Bronchiolitis

Bronchiolitis most commonly occurs in infants under 1 year of age, with the highest risk and severity in those younger than 12 weeks (3 months). 1

Primary Age Range

  • The American Academy of Pediatrics defines the target population for bronchiolitis as children from 1 month through 23 months of age. 1
  • Bronchiolitis is the most common lower respiratory infection in young children and the leading cause of hospitalization in those aged less than 1 year. 1
  • Approximately 90% of children are infected with RSV (the most common cause) within the first 2 years of life, with up to 40% developing lower respiratory tract infection during their initial infection. 2, 1

Peak Incidence and Severity by Age

Infants under 3 months represent the highest-risk group:

  • Most hospitalizations for bronchiolitis occur in infants under 3 months of age. 3
  • More than 50% of deaths from bronchiolitis occur in patients younger than 3 months. 3
  • Infants younger than 12 weeks are at significantly higher risk for severe disease requiring hospitalization. 1

Age-specific clinical patterns:

  • Infants 1-12 months present with more pronounced increased work of breathing, including tachypnea, nasal flaring, and intercostal retractions, and have higher risk of apnea (particularly those under 1 month and premature infants). 1
  • Children 12-24 months typically present with rhinitis and cough progressing to wheezing and rales, but generally compensate better for increased respiratory effort than younger infants. 1
  • The average age in clinical studies is approximately 10 months, with severity decreasing as age increases. 4

Epidemiologic Context

  • RSV bronchiolitis leads to more than 90,000 hospitalizations annually in the United States, with the vast majority in infants less than 1 year old. 1
  • The hospitalization rate for children under 1 year is 3,838 per 100,000 healthy children. 3
  • The cost of hospitalization for bronchiolitis in children less than 1 year old exceeds $700 million annually in the United States. 2

Critical Clinical Caveats

Neonates (under 1 month) require special consideration:

  • These infants fall outside the standard AAP guideline age range but can develop bronchiolitis. 1
  • They have substantially higher risk of severe disease, apnea, and serious bacterial infections (approximately 10% risk of SBI). 1, 5
  • Febrile neonates with bronchiolitis symptoms warrant more aggressive evaluation for concurrent bacterial infections. 5

Children outside the typical age range:

  • While bronchiolitis can occur beyond 24 months, these children may have different clinical presentations, management needs, and outcomes. 1
  • Children with persistent symptoms beyond 4 weeks may represent "post-bronchiolitis syndrome" rather than acute bronchiolitis. 1

References

Guideline

Bronchiolitis in Young Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Differential Diagnoses for Bronchiolitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.